The headline numbers for The Bank of New York Mellon (BK) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Gladstone Capital offers an 8.6% dividend yield. It trades just below NAV and sits at the low end of its 5-year valuation range. GLAD's portfolio is 90% senior secured debt, with increased defensiveness and 81% sponsor-backed loans, supporting credit quality. Net investment income covers the dividend at a 116% ratio and NAV per share rose sequentially.

Although the revenue and EPS for JPMorgan Chase & Co. (JPM) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

While the top- and bottom-line numbers for Delta (DAL) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Planet Labs (PL) climbed +12% on January 12, 2026, in response to the announcement of a multi-year, low nine-figure agreement with the Swedish Armed Forces. The stock gapped up on substantial volume, breaking through recent resistance.

While Intel's stock has booked nice gains over the last year, those largely don't relate to artificial-intelligence prowess. A KeyBanc analyst thinks that could be changing.

Day One Biopharmaceuticals (DAWN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

FCN shares beat industry gains as diversified consulting, solid liquidity and ongoing buybacks indicate modest earnings growth in 2026.

Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.

2026 is on a fresh start, and January is nearly halfway over. While we cannot slow the hands of time, we can look at it as an opportunity to make money.

I'm upgrading Centrus Energy (LEU) to Buy, which is reflective of the improved valuation and strategic progress in HALEU enrichment. LEU's unique position as the only U.S. HALEU producer aligns with surging demand from next-generation nuclear reactors. A $900 million DOE grant and multi-billion dollar expansion in Piketon, Ohio, strengthen LEU's growth trajectory.